Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution
Abstract Astatine-211 (211At)-labeled phenylalanine is expected to be a promising agent for targeted alpha-particle therapy for the treatment of patients with glioma. The existing reactions to prepare the labeled compound usually require organic solvents and metals that are toxic and hazardous to th...
Main Authors: | Yoshifumi Shirakami, Tadashi Watabe, Honoka Obata, Kazuko Kaneda, Kazuhiro Ooe, Yuwei Liu, Takahiro Teramoto, Atsushi Toyoshima, Atsushi Shinohara, Eku Shimosegawa, Jun Hatazawa, Koichi Fukase |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92476-6 |
Similar Items
-
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
by: Hiroki Kato, et al.
Published: (2021-07-01) -
Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [211At] NaAt in Mice: A Revisit
by: Yuwei Liu, et al.
Published: (2020-04-01) -
Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice
by: Atsushi Yagishita, et al.
Published: (2023-12-01) -
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
by: Xuhao Huang, et al.
Published: (2022-12-01) -
Enhancing the Therapeutic Effect of 2-<sup>211</sup>At-astato-α-methyl-L-phenylalanine with Probenecid Loading
by: Hirofumi Hanaoka, et al.
Published: (2021-11-01)